Sight Sciences financials at a glance
Year | Year | 2021 | 2022 | 2020 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$48.96M | $71.33M | $27.64M | $81.06M | $0.00M |
GM % | Gross Margin % |
|
82.41% | 82.67% | 66.68% | 85.34% | 0.00% |
OM | Operating Margin |
|
-105.15% | -117.70% | -116.45% | -70.66% | 0.00% |
EPS | Earnings Per Share |
|
$-2.36 | $-1.80 | $-1.14 | $0.00 | |
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
PR % | Payout Ratio % |
|
-0.00% | -0.00% | 0 | -0.00% | 0 |
Sha. | Shares |
|
47.31m | 47.59m | 0m | 48.75m | 48.75m |
OCF | Operating Cash Flow |
|
$-52.54M | $-75.97M | $-32.17M | $-47.18M | $0.00M |
FCF | Free Cash Flow |
|
$-53.35M | $-76.94M | $-33.12M | $-47.99M | $0.00M |
FCFS | Free Cash Flow Per Share |
|
$-2.00 | $-1.61 | $-3.54 | $-0.99 | $0.00 |